Fmoc-PEG4-Ala-Ala-ASN-PAB
CAS: 2055048-57-0
Ref. 3D-FHD04857
| 5mg | Descatalogado | ||
| 10mg | Descatalogado | ||
| 25mg | Descatalogado | ||
| 50mg | Descatalogado | ||
| 100mg | Descatalogado |
Información del producto
Nombre:
Fmoc-PEG4-Ala-Ala-ASN-PAB
Sinónimos:
- L-Aspartamide, N-[19-(9H-fluoren-9-yl)-1,17-dioxo-4,7,10,13,18-pentaoxa-16-azanonadec-1-yl]-L-alanyl-L-alanyl-N1-[4-(hydroxymethyl)phenyl]-
- N-[19-(9H-Fluoren-9-yl)-1,17-dioxo-4,7,10,13,18-pentaoxa-16-azanonadec-1-yl]-L-alanyl-L-alanyl-N1-[4-(hydroxymethyl)phenyl]-L-aspartamide
Descripción:
Fmoc-PEG4-Ala-Ala-ASN-PAB is a PEG protected peptide that belongs to the family of PEG products. It is a pegylated peptide, meaning it has been modified with polyethylene glycol (PEG) to enhance its stability and prolong its half-life in the body. Fmoc-PEG4-Ala-Ala-ASN-PAB is commonly used in pharmaceutical research and drug development due to its improved pharmacokinetic properties. Its PEGylation allows for increased solubility, reduced immunogenicity, and enhanced bioavailability. This makes it an ideal choice for applications requiring prolonged release or targeted delivery of therapeutic agents.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
848.9 g/mol
Fórmula:
C43H56N6O12
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
